Syndicated Market Reports
Source-verified market sizing, forecast models, and competition mapping across healthcare categories.
From syndicated market reports to bespoke primary research and live pipeline monitoring, Clarivant Health delivers verified intelligence for strategy, BD, and investment teams.
Built for procurement managers, strategy functions, and healthcare-focused investment teams who need intelligence they can defend in front of a board.
Source-verified market sizing, forecast models, and competition mapping across healthcare categories.
Continuous tracking of clinical trial milestones, approvals, and regulatory events.
Structured custom engagements tailored to specific strategic decisions and timelines.
Asset landscapes, differentiation mapping, and launch preparedness insights.
HTA pathways, reimbursement precedent, and payer-access strategy across key regions.
Decision-grade commercial and risk analysis for investment committees and portfolio teams.
Coverage across active clinical trials and regulatory submissions with rapid update cadence.
NDA, BLA, PMA, 510(k), CHMP, and major decision-event monitoring.
Forward view of Phase II/III data readouts with timing risk flags.
Commercial-context alerts after approvals, refusals, and label changes.
Biosimilar filing activity and key exclusivity milestones.
When your question does not fit a standard report, we build the research around your decision context.
CAR-T manufacturing services evaluation
Built a bottom-up model and expert-validated capacity assumptions for IC readiness.
EU launch sequencing for liquid biopsy
Ranked markets by reimbursement speed, infrastructure, and payer receptivity.